ATTN-ANX: Investigating Attention Patterns in Young People With Anxiety

Sponsor
King's College London (Other)
Overall Status
Unknown status
CT.gov ID
NCT03546946
Collaborator
South London and Maudsley NHS Foundation Trust (Other)
99
1
3
18.9
5.2

Study Details

Study Description

Brief Summary

Adolescents with elevated anxiety have been found to direct their voluntary and involuntary attention more readily toward threatening stimuli, and spend more time dwelling upon that stimuli. Various computerised tasks have been developed to attempt to retrain these "attention biases" back away from threat.

This study will test a newly developed intervention, that uses (eye-tracking) methods to track the gaze of the individual. This intervention is called Gaze-Contingent Music Reward Training (GC-MRT), and is designed to re-train the individual away from dwelling upon threatening stimuli (emotional faces), using their favourite music to re-infornce this learning.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Gaze-Contingent Music Reward Training
  • Behavioral: Control Training
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
99 participants
Allocation:
Randomized
Intervention Model:
Factorial Assignment
Masking:
Double (Participant, Outcomes Assessor)
Primary Purpose:
Basic Science
Official Title:
Investigating Attention Patterns in Young People With Anxiety
Actual Study Start Date :
Jun 5, 2018
Anticipated Primary Completion Date :
Jan 1, 2020
Anticipated Study Completion Date :
Jan 1, 2020

Arms and Interventions

Arm Intervention/Treatment
Experimental: Gaze-Contingent Music Reward Training

GCMRT for eight 20-minute sessions - twice per week over 4 weeks.

Behavioral: Gaze-Contingent Music Reward Training
Participants will hear their selected music track playing, dependent on their gaze location, when viewing a grid on neutral and negative faces.

Placebo Comparator: Control Training

Passive viewing task with continuous music for eight 20-minute sessions - twice per week over 4 weeks.

Behavioral: Control Training
Participants will hear their selected music track playing, regardless of their gaze location, when viewing a grid on neutral and negative faces.

No Intervention: No-Train Group

No active training.

Outcome Measures

Primary Outcome Measures

  1. Change in anxiety symtoms [Baseline and post-intervention (4 weeks), and at 3-month follow up.]

    Change in anxiety symptoms from baseline at 4-weeks on the Kiddie Schedule for Affective Disorders (KSADS), and at 3-month follow up

Secondary Outcome Measures

  1. Change in Self-report Anxiety [Baseline and post-intervention (4 weeks), and at 3-month follow up.]

    Change in self-report anxiety symptoms from baseline at 4-weeks on the Screen for Child Anxiety Related Disorders (SCARED), and at 3-month follow up.

  2. Change in Dwell time on negative faces [Baseline and post-intervention (4 weeks), and at 3-month follow up.]

    Change in dwell time on negative faces, from baseline at 4-weeks, using eye-tracking measures on a free-viewing attention task, and at 3-month follow up.

Eligibility Criteria

Criteria

Ages Eligible for Study:
12 Years to 18 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • 12-18 years of age upon study commencement

  • Diagnosed generalised or social anxiety disorder (assessed by SCID)

  • Informed written and witnessed consent

Exclusion Criteria:
  • Psychosis

  • Autism

  • Learning difficulties

  • Uncorrected abnormal vision

  • Current use of SSRIs

Contacts and Locations

Locations

Site City State Country Postal Code
1 King's College London London England United Kingdom SE58AF

Sponsors and Collaborators

  • King's College London
  • South London and Maudsley NHS Foundation Trust

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
King's College London
ClinicalTrials.gov Identifier:
NCT03546946
Other Study ID Numbers:
  • 225926
First Posted:
Jun 6, 2018
Last Update Posted:
Mar 25, 2019
Last Verified:
Mar 1, 2019
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by King's College London
Additional relevant MeSH terms:

Study Results

No Results Posted as of Mar 25, 2019